COVID-19 Update

As a public health precaution due to the novel coronavirus (COVID-19), the MoTrPAC study will be temporarily suspended as of Monday, March 23, 2020. We will be contacting all participants by telephone on a regular basis during this temporary suspension. In-person activities will be re-started when it is safe to do so.

The health and safety of all MoTrPAC participants and staff are top priorities for us. We are closely monitoring the coronavirus situation and will restart the study as soon as possible.

If you are interested in learning more about MoTrPAC, click here.

If you would like to complete the web screener to see if you might be eligible to participate in the study, click here.

Please note that we are continuing to screen interested individuals by telephone, but will wait to schedule any in-person appointments until the Centers for Disease Control and local health authorities indicate that it is safe to do so.

Molecular Transducers of Physical Activity Consortium (MoTrPAC)
MoTrPAC is a national research consortium designed to discover and perform preliminary characterization of the range of molecular transducers (the "molecular map") that underlie the effects of physical activity in humans. The program's goal is to study the molecular changes that occur during and after exercise and ultimately to advance the understanding of how physical activity improves and preserves health. The six-year program is the largest targeted NIH investment of funds into the mechanisms of how physical activity improves health and prevents disease.

The MoTrPAC program is supported by the NIH Common Fund and is managed by a trans-agency working group representing multiple NIH institutes and centers, led by the NIH Office of Strategic Coordination, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute on Aging, and National Institute of Biomedical Imaging and Bioengineering.